Skip to content

Author

J. McGuirk

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Incidence, Patterns, and Outcomes of Fungal Infections in Patients With Graft Versus Host Disease Requiring Systemic Steroids Following Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta Analysis.

BACKGROUND Graft-versus-host disease (GVHD) is a significant complication following allogeneic hematopoietic cell transplantation (HCT). Systemic corticosteroids, the standard treatment for GVHD, increase susceptibility to infections, including invasive fungal infections (IFIs). This study aimed to systematically revie...

M. Amin, Areeba Ismail, M. S. Shah et al. · 0 citations
Open access Oct 2026

Impact of Early Bloodstream Infections on Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis.

It is demonstrated that early bloodstream infections significantly alter clinical outcomes in allogeneic hematopoietic stem cell transplant recipients receiving PTCy-based GVHD prophylaxis, and the importance of enhanced antimicrobial surveillance and interventions to protect patients against high-risk pathogens.

M. Shahzad, M. Amin, Amna Bint I. Munir et al. · 0 citations
Open access Sep 2026

Sequencing BCMA-Directed Therapies in Relapsed/Refractory Multiple Myeloma: A Real-World Comparison of CAR T-Cell Therapy and Bispecific Antibodies

Simple Summary B-cell maturation antigen (BCMA)-directed therapies (BDT) are approved for the treatment of relapsed/refractory multiple myeloma (RRMM). Several treatment modalities exist including chimeric antigen receptor T-cell therapy (CAR-T), bispecific antibodies (BsAbs), and antibody-drug conjugates (ADC). The ef...

Osama M. Younis, Sencer Goklemez, Carmel Awadallah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.